Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intraarterial, intraarticular and intrathecal use. It increases X‑ray attenuation, allowing clearer visualization of vascular and tissue structures during radiographic procedures.\n\nGNH India supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iomeron is used in diagnostic imaging procedures that require enhanced vascular and tissue contrast.\n\n- Angiography: improves delineation of arterial and venous anatomy.\n- CT angiography: provides high‑resolution images of blood vessels in the head, neck and body.\n- Arthrography: enhances joint space visualization for orthopedic assessment.\n- Myelography: clarifies spinal canal structures during contrast‑enhanced studies.\n- Contrast‑enhanced CT of abdomen, pelvis and thorax: highlights organs and lesions for accurate diagnosis.

Adverse reactions may occur after administration of Iomeron.\n\nCommon Side Effects:\n- Warmth or flushing sensation at the injection site.\n- Metallic taste in the mouth.\n- Nausea or mild vomiting.\n- Transient headache.\n\nSerious or Rare Side Effects:\n- Anaphylactic or severe allergic reaction.\n- Acute renal impairment, especially in patients with pre‑existing kidney disease.\n- Hypotension or cardiovascular collapse.\n- Seizures or neurologic disturbances.\n- Pulmonary edema or severe respiratory distress.

Prior to using Iomeron, clinicians should consider several safety measures.\n\n- Renal function assessment: evaluate serum creatinine and eGFR.\n- Iodine allergy review: screen for previous contrast reactions.\n- Hydration: ensure adequate patient hydration before and after injection.\n- Dose minimisation: use the lowest effective volume for the intended study.\n- Thyroid monitoring: be aware of potential iodine‑induced thyroid dysfunction.\n- Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Iomeron may interact with other medicines that affect renal function or iodine handling.\n\nMajor Interactions (Avoid):\n- Metformin: risk of lactic acidosis in patients with impaired renal function after contrast exposure.\n- Thyroid hormone therapy: excess iodine can alter thyroid hormone levels.\n\nModerate Interactions (Monitor Closely):\n- NSAIDs and other nephrotoxic drugs: increase risk of contrast‑induced nephropathy.\n- Diuretics: may exacerbate volume depletion and renal impairment.\n- Aminoglycoside antibiotics: additive renal toxicity potential.\n- Radiopharmaceutical iodine: cumulative iodine load may affect thyroid function.